PLACENTEX ® Polydeoxyribonucleotide

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
51	Scleroderma	2

51. Scleroderma

Clinical trials : 525 / Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03388255 (ClinicalTrials.gov)	November 8, 2016	21/12/2017	Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases	A Phase IV, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of PLACENTEX ® ...	Scleroderma Disease	Drug: Polydeoxyribonucleotides	Mastelli S.r.l	Sintesi Research Srl	Terminated	18 Years	N/A	All	25	Phase 4	Italy
2	EUCTR2015-005100-28-IT (EUCTR)	18/07/2016	17/01/2022	A clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ administered intra-muscular in p ...	A phase IV, single-arm, open-label clinical trial to evaluate the efficacy and safety of PLACENTEX ¿ ...	Fibrotic and atrophic cutaneous lesions in localized scleroderma diseases. MedDRA version: 20.0;Leve ...	Trade Name: PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿ Product Name: PLACENTEX ¿ Polydeoxyribonu ...	MASTELLI SRL	NULL	Not Recruiting			Female: yes Male: yes	45	Phase 4	Italy

First Previous1Next Last